ACE inhibition and low levels of ACE-2 receptors lead to increased renal potassium excretion and sodium retention, resulting in electrolyte imbalances such as hypokalemia and hypernatremia (Beck et al., 2020 ▶). The gene discussed is ACE; the disease is Hypernatremia.